Sofinnova Venture Partners IX, L.P. - 19 Dec 2025 SCHEDULE 13D/A Report for NextCure, Inc. Common Stock, $0.001 par value (NXTC)
- Filing Manager
- Sofinnova Venture Partners IX, L.P.
- Reporting Manager
- Sofinnova Venture Partners IX, L.P. ("SVP IX")
- Symbol
- NXTC
- Shares outstanding
- 3,135,972 shares
- Disclosed Ownership
- 222,654 shares
- Ownership
- 7.1%
- Form type
- SCHEDULE 13D/A
- Filing time
- 05 Mar 2026, 06:06:07 UTC
- Date of event
- 19 Dec 2025
- SEC
- View on sec.gov
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sofinnova Venture Partners IX, L.P. ("SVP IX") | 7.1% | 222,654 | 222,654 | 0 | /s/ Nathalie Auber | Nathalie Auber/Attorney-in-Fact | 0001612133 |
| Sofinnova Management IX, L.L.C. ("SM IX") | 7.1% | 222,654 | 222,654 | 0 | /s/ Nathalie Auber | Nathalie Auber/Attorney-in-Fact | |
| Dr. James I. Healy ("Healy") | 7.1% | 222,654 | 222,654 | 0 | /s/ Nathalie Auber | Nathalie Auber/Attorney-in-Fact |